SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458508093679v1
14/8/1026    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Di Pauli, F
Right arrow Articles by Berger, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Pauli, F
Right arrow Articles by Berger, T
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

research-article

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

F Di Pauli

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

M Reindl

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

R Ehling

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

F Schautzer

Department of Neurology, County Hospital, Villach, Austria

C Gneiss

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

A Lutterotti

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

EJ O'Reilly

Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA

KL Munger

Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA

F Deisenhammer

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

A Ascherio

Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

T Berger

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria thomas.berger{at}i-med.ac.at

Background

Cigarette smoking increases the risk for development of multiple sclerosis and modifies the clinical course of the disease. In this study, we determined whether smoking is a risk factor for early conversion to clinically definite multiple sclerosis after a clinically isolated syndrome.

Methods

We included 129 patients with a clinically isolated syndrome, disseminated white-matter lesions on brain magnetic resonance imaging, and positive oligoclonal bands in the cerebrospinal fluid. The patients' smoking status was obtained at the time of the clinically isolated syndrome.

Results

During a follow-up time of 36 months, 75% of smokers but only 51% of non-smokers developed clinically definite multiple sclerosis, and smokers had a significantly shorter time interval to their first relapse. The hazard ratio for progression to clinically definite multiple sclerosis was 1.8 (95% confidence interval, 1.2–2.8) for smokers compared with non-smokers (P = 0.008).

Conclusions

Smoking is associated with an increased risk for early conversion to clinically definite multiple sclerosis after a clinically isolated syndrome, and our results suggest that smoking is an independent but modifiable risk factor for disease progression of multiple sclerosis. Therefore, it should be considered in the counseling of patients with a clinically isolated syndrome.

Key Words: clinically isolated syndrome • disease progression • multiple sclerosis • smoking

This version was published on September 1, 2008

Multiple Sclerosis, Vol. 14, No. 8, 1026-1030 (2008)
DOI: 10.1177/1352458508093679


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement